Table 1.
mRNA Targets of miR-137 in Glioma Development and Function
| Targets | Major Functions | References |
|---|---|---|
| LSD1 | promoting NSC or GSC proliferation and inhibiting differentiation | 25 |
| EZH2 | promoting proliferation and angiogenesis of glioma cells | 58 |
| RTVP-1 | promoting GSCs’ self-renewal and inhibiting their differentiation | 6 |
| TCF4 | binding to β-catenin and triggering Wnt/β-catenin signaling | 61 |
| CDK6 | cell-cycle regulator | 17 |
| COX2 | promoting glioma cell proliferation and invasion | 41 |
| EGFR | increasing cell growth and decreasing cell apoptosis | 55 |
| FOXK1 | promoting proliferation and cell-cycle transition and inhibiting apoptosis | 62 |
| PDGFRα | increasing cell growth and reducing cell apoptosis | 60 |
| ZO-2 | angiogenesis and blood tumor barrier permeability | 28 |
| CSE1L | inhibiting glioma cell proliferation, invasion | 63 |
| Msi1 | promoting self-renewal, proliferation, tumorigenesis | 60 |
| RasGRF1 | promoting glioma cell proliferation and inhibiting apoptosis | 23 |
| Rac1 | promoting glioma cell proliferation and inhibiting apoptosis | 50 |
| CENPE | promoting pediatric high-grade glioma cell proliferation | 45 |
| PTP4A3 | promoting GBM cell proliferation, migration, and invasion | 64 |
| SP1 | promoting cell proliferation and invasion | 30 |
| FOXC1 | angiogenesis and blood tumor barrier permeability | 28 |
| TRIM24 | drug resistance | 31 |
| CAR | drug resistance | 65 |
| STC1 | promoting metastasis and cell proliferation | 57 |
| CXCL12 | promoting cell proliferation and invasion | 54 |
| NUCKS1 | promoting cell proliferation and drug resistance | 66 |
| BCL2 | inhibiting apoptosis | 50 |
| SLC1A5 | regulating cell growth, survival, and proliferation | 51 |
GBM, glioblastoma.